Guangdong Danxia Biological Pharmaceutical Co.,Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guangdong Danxia Biological Pharmaceutical Co.,Ltd. - overview
Established
2022
Location
Shaoguan, Guangdong, China
Primary Industry
Pharmaceuticals
About
Based in Shaoguan, China, and established in 2002, Guangdong Danxia Biological Pharmaceutical Co. ,Ltd. operates as a pharmaceutical company that focuses on R&D, sales, and production of blood products. The company acquired the drug production license in 2009.
The company acquired the drug good manufacturing practice of medical products (GMP) certificate in 2013. The company provides blood products. The business of the company includes development, production and sales of blood products. The company's products include human albumin, human immunoglobulin and fibrinogen.
Current Investors
Ch-gemstone Health Capital Management, GTJA Investment Group
Primary Industry
Pharmaceuticals
Sub Industries
Healthcare, Pharmaceuticals
Website
www.gd-danxia.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Guangdong Danxia Biological Pharmaceutical Co.,Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Guangdong Danxia Biological Pharmaceutical Co.,Ltd. | - | ||||||||
| Buyout | Completed | Guangdong Danxia Biological Pharmaceutical Co.,Ltd. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.